Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "Novo Nordisk A/S" (Page 2)

FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy

By FinMar NewsMarch 19, 2026

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersThe Food and…

Jim Cramer’s update on our AI stocks and the rest of the portfolio

By FinMar NewsMarch 2, 2026

On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio Analysis ran through each stock in the portfolio.…

Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%

By FinMar NewsFebruary 24, 2026

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersNovo Nordisk on…

CEO says it will get worse before it gets better

By FinMar NewsFebruary 9, 2026

Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise pre-released its 2026 forecast late Tuesday, sending shares…

Novo Nordisk sues Hims & Hers over compounded obesity drugs

By FinMar NewsFebruary 9, 2026

Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity…

This pharma stock just got whacked — there’s still a major catalyst ahead

By FinMar NewsJanuary 18, 2026

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading…

Anthropic’s Amodei siblings may hold the key to generative AI

By FinMar NewsJanuary 10, 2026

SAN FRANCISCO — Daniela Amodei has an energy that’s hard to place — warm, unhurried, immediately present. She swept into a sunlit room on the ground…

Wall Street deals 2025 under Trump: Tariffs, uncertainty slow M&A

By FinMar NewsDecember 19, 2025

The Wall Street Bull statue covered in snow on Nov. 15, 2018.Erik Mcgregor | Lightrocket | Getty ImagesWall Street expected U.S. mergers and acquisitions to roar…

Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound 

By FinMar NewsDecember 18, 2025

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.Ore Huiying | Bloomberg | Getty…

Eli Lilly hits $1 trillion market value, first for health care company

By FinMar NewsNovember 24, 2025

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesEli Lilly reached…

Previous 1 2 3 4 … 7 Next
Energy News

Oil prices rise as as market waits on deal to open Strait of Hormuz

Hungary’s nuclear power shortage opens door to market liberalisation

Oil prices little changed on negotiations to manage ship traffic in Strait

NUPRC seeks deeper industry collaboration to strengthen Nigeria’s energy

Banks News

Local bank lending to MSMEs remains sluggish

Chinabank posted record January-June profit of P14.5B

Singapore banks offload risk to private credit

Otedola Targets 51% Stake in First HoldCo

Real Estate News

3 New York neighborhoods that capture the state’s character

REMAX misses the mark as revenue falls 6%

Lehi Real Estate Snapshot: July 2026

North Dakota Farm Real Estate Values Rise 3.8% in 2026

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com